Allergologiepraktijk Arnhem/Radboud/Rijnstate
Arnhem, Gelderland, 6824 BJ, Netherlands
NCT Number: NCT01137357
In vitro studies reveal immunomodulatory effects of probiotic bacteria that are strain-dependent. Differential immunomodulatory in vitro capacities can not be extrapolated directly to in vivo efficacy. Thus, in vitro screening should be followed by comparative analysis of the selected immunomodulatory probiotic strains in an in vivo setting. Birch pollen allergy is one of the most common forms of respiratory allergy in European countries, and recognized by a Th2-skewed immune system. Five Lactobacillus strains will be evaluated for their immunomodulatory properties in birch pollen sensitive subjects outside the hay fever season. A double-blind placebo-controlled parallel study will be performed in which subjects with a proven birch pollen allergy will consume one of 5 different probiotic yoghurts containing 4 L. plantarum strains and 1 L. casei strain or a placebo yoghurt. Blood samples are collected at the start and after 4 weeks. Immune parameters are determined in serum and peripheral blood mononuclear cell cultures (hPBMC) derived from these subjects.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Arnhem, Gelderland, 6824 BJ, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intake of yoghurt during 4 weeks
Intake of yoghurt during 4 weeks
Intake of yoghurt during 4 weeks
Rijnstate Hospital
Other
Acronym: PROMISA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05960266
Hay Fever, Hypersensitivity
Zurich, Switzerland
View Trial DetailsNCT06457269
Actinomycetales Infections, Acute Bronchitis
Nanchong, Sichuan, China
View Trial DetailsNCT04622917
Allergic Rhinitis, Hay Fever
Lund, Skåne County, Sweden
View Trial DetailsNCT04326309
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial Details